Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W van Oosten

Showing results (1-10 of 77) with videos related to

Pageof 8
Sort By:
Clinical and Experimental Rheumatology|September 19, 2008
Axonal neuropathy with prolonged sulphasalazine useM Liedorp, A E Voskuyl, B W Van Oosten
Nederlands Tijdschrift Voor Geneeskunde|August 26, 2004
[New diagnostic criteria for multiple sclerosis in clinical practice]B W Van Oosten, F Barkhof, C H Polman
Neurology|September 18, 2013
Author responseMike P Wattjes, Femke Visser, Bob W van Oosten
The New England Journal of Medicine|September 17, 2013
Case reports of PML in patients treated for psoriasisBob W van Oosten, Joep Killestein, Mike P Wattjes
The New England Journal of Medicine|August 6, 2015
PML in Patients Treated with Dimethyl FumarateDennis J Nieuwkamp, Jean-Luc Murk, Bob W van Oosten
The New England Journal of Medicine|January 23, 2016
More on PML in Patients Treated with Dimethyl Fumarate. Author replyJean-Luc Murk, Dennis J Nieuwkamp, Bob W van Oosten
Drugs|February 1, 1995
Multiple sclerosis therapy. A practical guideB W van Oosten, L Truyen, F Barkhof, et al.
Drugs|November 7, 1998
Choosing drug therapy for multiple sclerosis. An updateB W van Oosten, L Truyen, F Barkhof, et al.
Nature Clinical Practice. Neurology|August 26, 2006
The role of spinal cord imaging in the diagnosis of multiple sclerosisJessica M Nielsen, Frederik Barkhof, Bob W van Oosten, et al.
Multiple Sclerosis and Related Disorders|March 23, 2019
High work absence around time of diagnosis of multiple sclerosis is associated with fatigue and relapse rateD Doesburg, A Vennegoor, B M J Uitdehaag, et al.
Pageof 8

Showing results (1-10 of 77) with videos related to

Sort By:
Pageof 8
Clinical and Experimental Rheumatology|September 19, 2008
Axonal neuropathy with prolonged sulphasalazine useM Liedorp, A E Voskuyl, B W Van Oosten
Nederlands Tijdschrift Voor Geneeskunde|August 26, 2004
[New diagnostic criteria for multiple sclerosis in clinical practice]B W Van Oosten, F Barkhof, C H Polman
Neurology|September 18, 2013
Author responseMike P Wattjes, Femke Visser, Bob W van Oosten
The New England Journal of Medicine|September 17, 2013
Case reports of PML in patients treated for psoriasisBob W van Oosten, Joep Killestein, Mike P Wattjes
The New England Journal of Medicine|August 6, 2015
PML in Patients Treated with Dimethyl FumarateDennis J Nieuwkamp, Jean-Luc Murk, Bob W van Oosten
The New England Journal of Medicine|January 23, 2016
More on PML in Patients Treated with Dimethyl Fumarate. Author replyJean-Luc Murk, Dennis J Nieuwkamp, Bob W van Oosten
Drugs|February 1, 1995
Multiple sclerosis therapy. A practical guideB W van Oosten, L Truyen, F Barkhof, et al.
Drugs|November 7, 1998
Choosing drug therapy for multiple sclerosis. An updateB W van Oosten, L Truyen, F Barkhof, et al.
Nature Clinical Practice. Neurology|August 26, 2006
The role of spinal cord imaging in the diagnosis of multiple sclerosisJessica M Nielsen, Frederik Barkhof, Bob W van Oosten, et al.
Multiple Sclerosis and Related Disorders|March 23, 2019
High work absence around time of diagnosis of multiple sclerosis is associated with fatigue and relapse rateD Doesburg, A Vennegoor, B M J Uitdehaag, et al.
Pageof 8